Choose your font:
 Arimo
 Merriweather
 Mukta Malar
 Open Sans Condensed
 Rokkitt
 Source Sans Pro
 Login


 English 
 Français 
 Português 

[Valid RSS] RSS
bar

Database - Alliance francophone pour l'accouchement respecté (AFAR)

Description of this bibliographical database (AFAR website)
YouTube channel (tutorial)

https://afar.info/id=1977

Created on : 15 May 2006
Modified on : 02 Nov 2018

 Modify this record
Do not follow this link unless you know an editor’s password!


Share: Facebook logo   Tweeter logo   Hard

Bibliographical entry (without author) :

Methods of induction of labour. {Angleterre}. Revue. Curr Opin Obstet Gynecol. 1997 Dec;9(6):375-8.

Author(s) :

el Refaey H, Jauniaux E.

Year of publication :

1997

URL(s) :

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=…

Résumé (français)  :

Abstract (English)  :

Several research groups around the world reported on the use of the drug misoprostol in the medical management of miscarriage, abortion and induction of labour. This review examines the evolution of interest in this drug, with special emphasis on its role in induction of labour.

The induction of labor by prostaglandin agents has been a central research focus for the past 30 years, but their use has been compromised by the high incidence of gastrointestinal side effects. During the late 1970s, the research focus shifted to sequential vaginal administration of different prostaglandin analogues. Currently, the pharmaceutical industry is especially interested in the role of misoprostol in inducing uterine contractibility. Required first, however, is the determination of the correct dosage and frequency that will induce effective uterine contractions without producing uterine hyperstimulation and adverse effects on the fetal heart rate. Because of its thermostability, efficacy, and low cost, the therapeutic use of misoprostol is expected to increase throughout the world in the years ahead.

Sumário (português)  :

Comments :

Argument (français) :

En raison de sa thermostabilité, de son efficacité et de son faible coût, l’utilisation thérapeutique du misoprostol devrait augmenter dans le monde entier au cours des prochaines années.

Argument (English):

Because of its thermostability, efficacy, and low cost, the therapeutic use of misoprostol is expected to increase throughout the world in the years ahead.

Argumento (português):

Devido à sua estabilidade térmica, eficácia e baixo custo, espera-se que o uso terapêutico do misoprostol aumente em todo o mundo nos próximos anos.

Keywords :

➡ post-term pregnancy ; misoprostol (Cytotec) ; abortion ; pregnancy termination for medical reason

Author of this record :

Cécile Loup — 15 May 2006
➡ latest update : Bernard Bel — 02 Nov 2018

Discussion (display all languages)
 
➡ Only identified users



 I have read the guidelines of discussions and I accept all terms (read guidelines)

barre

New expert query --- New simple query

Creating new record --- Importing records

User management --- Dump database --- Contact

bar

This database is managed by Alliance francophone pour l'accouchement respecté (AFAR, https://afar.info)
affiliated with Collectif interassociatif autour de la naissance (CIANE, http://ciane.net).
It is fed by the voluntary contributions of persons interested in the sharing of scientific data.
If you agree with this project, you can support us in several ways:
(1) contributing to this database if you have a minimum training in documentation
(2) or financially supporting AFAR (see below)
(3) or joining the AFAR (or another society affiliated with CIANE).
Sign in or create an account to follow changes or become an editor.
Contact afar.association(arobase)gmail.com for more information.

Valid CSS! Valid HTML!
Donating to AFAR (click “Faire un don”) will help us to maintain and develop sites and public
databases towards the support of parents and caregivers’ informed decisions with respect to childbirth